Cancer patient derived organoids (PDO)

PDO Hepatoxicity Assessment In-Vivo Studies: ODX & PDX IF Imaging Drug Testing

The Organoid Lab integrates fresh tissue acquisition, processing to culture of patient-specific tumor organoid. We have to date handled a variety of cancer types, including colorectal cancer (CRC), liver cancer, glioblastoma (GBM), sarcomas, lung adenocarcinoma, pancreatic adenocarcinoma and breast cancer, to support laboratory research and personalized drug testing to inform treatment options.

Liver cancer
Renal carcinoma
Lung adenocarcinoma
Pancreatic adenocarcinoma
Our PDOs create a tumor "avatar" ex-vivo that maintain the parental tumor’s characteristics.